Medscape reports that people with hidradenitis suppurativa begin GLP-1 drugs sooner in their disease course than people with psoriasis do.
Recap by typeshit. Full story at Medscape.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Researchers reviewed posts from 13,589 users, with increased appetite and fatigue most common. Lilly says anyone selling retatrutide to consumers is breaking the law.
An NIH study is recruiting to see if an investigational weight loss medication reduces alcohol use and improves liver health.
Loading…